TWST - Twist Bioscience Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$64.40
DETAILS
HIGH:
$80.00
LOW:
$52.00
MEDIAN:
$65.00
CONSENSUS:
$64.40
UPSIDE:
6.32%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 50.7% |
| EBIT Margin | -20.4% |
| EBITDA Margin | -13.8% |
| Operating Margin | -36.2% |
| Pretax Margin | -20.4% |
| Cont. Ops Margin | -20.6% |
| Net Margin | -20.6% |
| Bottom Line Margin | -20.6% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 3.64 |
| Quick Ratio | 3.33 |
| Solvency Ratio | -0.313 |
| Cash Ratio | 2.00 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-21.67
Peers avg: 44.4
|
| PEG Ratio | 0.34 |
| Forward PEG | 0.34 |
| Price/Book | 3.56 |
| Price/Sales | 4.47 |
| Price/FCF | -22.25 |
| Price/Op Cash Flow | -35.34 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.2139 |
| Debt/Equity | 0.2903 |
| Debt/Capital | 0.2250 |
| Long-Term Debt/Capital | 0.1155 |
| Financial Leverage | 1.36 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 1.46 |
| Operating Cash Flow Ratio | -0.521 |
| Operating Cash Flow/Sales | -12.6% |
| Free Cash Flow/Operating Cash Flow | 158.8% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -3.82 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -3.45 |
| Operating Cash Flow Coverage | -0.35 |
| Capital Expenditure Coverage | -1.70 |
| Dividend + Capital Expenditure Coverage | -1.70 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 6.30 |
| EPS | -1.299 |
| Debt/Share | 2.2960 |
| Cash/Share | 3.89 |
| Book Value/Share | 7.91 |
| Tangible BV/Share | 6.31 |
| Equity/Share | 7.91 |
| Operating Cash Flow/Share | -0.796 |
| Capital Expenditure/Share | 0.468 |
| FCF/Share | -1.265 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.009 |
| Earnings Before Tax/EBIT | 0.565 |
| Price/Fair Value | 3.56 |
| Debt/Market Cap | 0.0449 |
| Effective Tax Rate | -0.9% |
| Enterprise Value Multiple | -31.43 |